SEC EDGAR CompanyFacts fact · reporting period
China SXT Pharmaceuticals, Inc.: revenue
One fact, its scope and the complete path back to the official record.
Reported value
$1.972M{"amount": 1971679, "concept": "us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax", "currency": "USD"}- Metric
- revenue
- Period
- 2022-04-01 – 2023-03-31
- Status
- current
- Source
- SEC EDGAR CompanyFacts
Provenance
Source licenseUS-PD-17USC105
Retrieved2026-08-19T17:38:17.916777+02:00
Raw response SHA-256
f7bde1a401b286c74a2fd824ee1df541…Official-identifier path
https://factanker.com/fact/sec/cik-0001723980/revenue/2023-03-31 (CIK, metric, reporting date)History
- supersedes {"amount": 1971679, "concept": "us-gaap:Revenues", "currency": "USD"} (evidence 0001213900-23-061294)
Why this page exists
The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.